NIGMS

The research team is developing a computational system for studying the relationship between RNA structure and function.

The firm will use the award to develop silica nanomaterial for use with many sample types, including blood, cultured cells, and pathogens.

The effort, dubbed the National Resource for Translational and Developmental Proteomics, aims to improve on the technology and train others in its use.

The funds will be used to expand the PharmGKB database and support the activities of the Clinical Pharmacogenetics Implementation Consortium.

Vanderbilt received the grant from NIGMS to establish a new personalized medicine and pharmacogenomics research center.

The grant will help create the new core as part of the existing South Carolina Center of Biomedical Research Excellence (COBRE) for cardiovascular disease.

Just One for You

The US National Institute of General Medical Sciences announces a plan to limit grants to already well-supported investigators.

NEW YORK (GenomeWeb) – The National Institute of General Medical Sciences will provide up to $2 million per year to renew funding for each of the National Centers for Systems Biology, pending approval of renewal applications, the institute said in an announcement Monday.

NEW YORK (GenomeWeb) – The National Institute of General Medical Sciences plans to spend up to $2.4 million in 2015 to fund the Pharmacogenomics Knowledge Base (PharmGKB), a program that supports pharmacogenomics researchers, and has opened

NEW YORK (GenomeWeb) – The National Institute of General Medical Sciences plans to fund efforts to develop new resources that investigators focused on pharmacogenomics can use to speed up their research activities or to implement them into practice.

Pages

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.